|
Post by kc on Mar 4, 2017 14:35:09 GMT -5
|
|
|
Post by kc on Mar 3, 2017 19:03:42 GMT -5
Such a disappointing time. I do hope one day in the future we get to see the benefit of our Investment. I guess we are on the ship to the very end . I just hope we get a life preserver before it goes down. I don't know if management is really doing fair job of trying to sell the product or if they should be selling The company.
At this point I need a wing and a prayer to get me by for a better day.
|
|
|
Post by kc on Mar 1, 2017 23:49:29 GMT -5
This reverse split is about keeping the company alive long enough to get the label changed and sell afrezza. I know I am a broken record. We have visual proof afrezza works better to control post meal blood glucose levels. we have the continuous glucose monitors. Proof is not enough? Do you see how high the blood glucose levels go for people on subq fast acting insulins? Do you see how low they can go in their sleep? We have proof. Perhaps the physicians liked it when they were in control and people would come in with their blood glucose reading written down. So easy to blame the patient for their blood glucose levels. The blood glucose levels are not the fault of the subq insulin? It is my conjecture that, collusion is involved with the demise of the stock price. Must kill afrezza and mannkind before the truth be known.
The physicians? inexplicable.
I have struggled with this for a long time and I don't know if we will ever know the full truth about Big Pharma "collusion" with Afrezza. Is there some type of it? Maybe. But I personally don't believe Novo's management is in communication with financial institutions on bleeding out the company and killing Afrezza. The truth is nobody wants to touch this drug right now as far as partnerships. Where are the regional partnerships that were first discussed over a year ago? Why is MNKD not forming some/any type of partnership with a mid-level pharma (Novatris, Takeda, Bayer) to add this innovative diabetes drug to their portfolio in return for much needed cash? MNKD seems to be on their own right now and we are entrusting them to turn it around and gain traction. It's basically a coin flip at this point. No way to prove what big Pharma has done. But they all have investments and start up companies through a shell company. They probably use those dollars you also play games with stocks of companies they do not like.
|
|
|
Post by kc on Mar 1, 2017 23:47:56 GMT -5
wildpig your logic only works when you make incorrect assumptions, as is frequently done at Seeking Alpha, then argue against the truth. You will have better luck there than here. Goodbye piggy Fortunately for me and many other readers we do not even go to SeekingAlpha as that is FUD central.
|
|
|
Post by kc on Mar 1, 2017 12:52:35 GMT -5
A meeting like this will be very fast. Call to order, reading what the meeting is about, asking anybody with their proxies to register and turn them in. Then closing. Count the ballots and come back and make an announcement. Then conclude the meeting. All done in the period of less than 30 minutes
|
|
|
Post by kc on Feb 21, 2017 13:37:30 GMT -5
Not sure how they would publish it in the document if they had sold already. that is not clear to me?
|
|
|
Post by kc on Feb 21, 2017 13:33:32 GMT -5
Reviewing the numbers on page 12 indicates to me that the Mann Family still controls 42.4% since this is the number that was published on the shareholder filing I would assume that this is correct.
files.shareholder.com/downloads/AMDA-22AIJ9/3935108837x0xS1193125-17-39440/899460/filing.pdf
Page 12: Name and Address of Beneficial Owner Number of Shares Percent of Total Greater than 5% Stockholders The Mann Group LLC(1) 89,652,250 18.7% 12744 San Fernando Road Sylmar, CA 91342 The Alfred E. Mann Living Trust(2) 114,102,161 23.7%
Page 13: What I don't understand is the language on the following page that applies to the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options that both the Mann entities and the management team has available. I assume it means nothing other than based on their contract they have rights to the outstanding options in the event of some right to exercise the options.
(3) Includes 2,234,732 shares which Mr. Pfeffer has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (4) Includes 1,295,805 shares which Dr. Thomson has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (5) Includes 247,486 shares which Dr. Urbanski has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (6) Includes 332,300 shares which Mr. Castagna has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (7) Includes 176,333 shares which Mr. Consiglio has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (8) Includes 176,333 shares which Dr. Friedman has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (9) Includes 176,338 shares which Mr. Kresa has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (10) Includes 176,333 shares which Mr. MacCallum has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (11) Includes 176,333 shares which Mr. Nordhoff has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (12) Includes 71,198 shares which Dr. Shannon has the right to acquire within 60 days of February 1, 2017 pursuant to the exercise of outstanding options. (13) Includes the shares described in notes (3) through (12) above, as well as 643,409 shares underlying a stock option that another executive officer has the right to acquire within 60 days of February 1, 2017.
|
|
|
Post by kc on Feb 17, 2017 9:59:38 GMT -5
Shares are really flat this AM. Bid seems to be there but no sellers? The perfect storm is upon us. The company needs to make something happen that is positive by the 1st Quarter Conf call.
|
|
|
Post by kc on Feb 16, 2017 12:44:27 GMT -5
The right vote is yes if you want to see the company succeed and implement their long term plan. While its distasteful to have seen this train wreck over the last 3+ years since the product was approved by the FDA, its important to allow the company what ever room they need to restructure their shares without having to file for CHAPTER 11 which would destroy any chance of common shareholders eventually getting value for their shares.
Take the emotion out of it and vote yes for the Reverse split. Jeez kc, if we could do that, I would have sold my shares in 2015 at around $3-3.50, instead of 2016 and 2017 at around .65-.98 Kball, I understand your point. Would have, Should have could have. Back in mid 2015 could have sold out with that short spike to 7.00. But didn't.
|
|
|
Post by kc on Feb 16, 2017 11:41:41 GMT -5
I too voted yes. I have faith in Matt, Mike and the rest of the team no matter how they managed the company in the past. Just this time last year, it was a terrible uphill climb and Mike wasn't even on board as yet. Alot has happened to keep the company afloat in these past twelve months and I'm not sure any other CEO could have done any better with the cards that were dealt. Looking ahead I too see a company that the big three pharmas (SNY,NVO and LLY)hope to deal a Bankruptcy as well. However as long as the users of Afrezza keep the flame lit and never give in, then MNKD will succeed and Afrezza I believe will be the best selling drug ever.JMHO Hans! welcome aboard and your very accurate comment.
|
|
|
Post by kc on Feb 16, 2017 11:39:22 GMT -5
The right vote is yes if you want to see the company succeed and implement their long term plan. While its distasteful to have seen this train wreck over the last 3+ years since the product was approved by the FDA, its important to allow the company what ever room they need to restructure their shares without having to file for CHAPTER 11 which would destroy any chance of common shareholders eventually getting value for their shares.
Take the emotion out of it and vote yes for the Reverse split.
|
|
|
Post by kc on Feb 15, 2017 13:48:09 GMT -5
I think we have a ticking time bomb. Not sure who it benefits. Hopefully us long term. Its all about sales.
1,327,445 share at 1:49 pm.
|
|
|
Post by kc on Feb 14, 2017 9:57:37 GMT -5
Hi MN, I am from Singapore and working in IT. I am not sure how I can help to find the information you are looking for. I have few friends here who are type 2. I explained them with whatever knowledge I have and they are eagerly awaiting for AFREZZA. Yash, does the Gov have their own drug approval organization or do they rely on the Drugs being approved by the FDA or EMA type organizations.
|
|
|
Post by kc on Feb 13, 2017 13:35:26 GMT -5
Do not all of there trades need to be filed with the SEC? No doubt the shares are dispersed among dozens of legal entities that allow them to circumnavigate the disclosure rules...
Or by other family members who own them directly and their friends.
|
|
|
Post by kc on Feb 13, 2017 11:40:57 GMT -5
Stock is doing well. Can we conclude the market loves the prospect of an R/S? Or is this sort of a celebration of the new sales force hitting the streets (and maybe a few Dr's offices). Hopefully, they'll be visiting more than Taco Bell and Starbucks. Perhaps evidence that the Mann Family and Foundation still holds 203 million shares. Remaining committed to Afrezza and the MannKind. Market reaction to seeing that the board is prepared to fight to survive so that they can prove product is a viable drug for diabetics in the USA and eventually world wide.
|
|